CYDY Shareholders: Anyone who holds stock in CytoDyn is

New Post Public Reply Private Reply Replies (3) Message Board
USS JOHNSTON
755
CYDY Shareholders:

Anyone who holds stock in CytoDyn is invited to sign a petition that requests leniency in sentencing for our former CEO, Nader Pourhassan.

https://www.change.org/supportnaderpourhassan

He was terminated at CytoDyn on 24 Jan, 2002, and later convicted (9 Dec 2024) on multiple counts of securities fraud, wire fraud, and insider trading. A sentencing date has not yet been published.

I have never met or spoken with Mr Pourhassan or anyone from his legal team or family. However, I have heard many stories of how he helped people save loved ones with Leronlimab, and I'm sponsoring this petition because I believe he did not act with malicious intent. I believe his passion and enthusiasm got the better of him, and being an outsider to the medical/pharma world and (probably) being ignorant of the narrow legal road the CEO of a publicly traded company has to walk, he said and did things that crossed the line(s).

I don't defend his behavior. This is just a petition to request leniency in sentencing because I believe him to be, fundamentally, a good man.

I will keep the petition up until Friday, 21 March. I will also post it on Stocktwits and Reddit. I don't know if they'll allow me to keep it up, we'll find out. At the end of Friday, 21 March, I will forward the completed petition to NP's family, I know someone who has an email address that will get it there.

I realize some or many CYDY shareholders may not harbor good will for our former CEO. I understand. Just be aware that this petition is not a request to relitigate or challenge the verdict, it is only a request for leniency.



On a separate note, it did raise my blood pressure to read the comments by the prosecution because they were, in my opinion, willfully ignorant of the evidence that supports Leronlimab's efficacy. For example -

1. "Inspector in Charge Eric Shen of the U.S. Postal Inspection Service (USPIS) Criminal Investigations Group. “In this case, these individuals took advantage of the dream of a possible new treatment for HIV and exploited investors, while dashing the hopes of many waiting for a cure."

2. “The defendants lied to investors and the public — including during the height of the COVID-19 pandemic — about a drug that purportedly treated HIV and COVID-19 in order to artificially inflate CytoDyn’s stock price,” said Principal Deputy Assistant Attorney General Nicole M. Argentieri, head of the Justice Department’s Criminal Division."

In short, if you wish to ask for leniency in the sentencing of Dr Pourhassan, please hit the link and sign the petition. He did tremendous things for the company, and without his efforts, I believe CytoDyn would not have what may be one of the most amazing molecules in the world.

https://www.change.org/supportnaderpourhassan
4

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 2

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Into bluebird bio, Inc.’s Acquisition Proposal

Updated Category News Views 167

Understanding the Investigation into bluebird bio, Inc. Recent developments have captured the attention of shareholders and the financial community regarding bluebird bio, Inc. (NASDAQ: BLUE). Rowley Law PLLC has initiated an investigation exploring possible violations of securities law associated with the company’s proposed acquisition. This acquisition is a joint...

Continue Reading
Unwind in Paradise: The Seminyak Beach Resort's Escape

Updated Category News Views 105

Experience Tranquility at The Seminyak Beach Resort & Spa The Seminyak Beach Resort & Spa invites travelers everywhere to immerse themselves in the serene beauty of Bali with its new Seaside Escape package. This luxurious beachfront haven is celebrated for its genuine Balinese artistry and exceptional service, perfectly catering to those who seek a unique blend of...

Continue Reading
Lyte Fiber Launches Advanced Network to Enhance Connectivity

Updated Category News Views 468

Lyte Fiber Unveils Innovative Fiber Network Project Lyte Fiber, LLC is making significant strides in enhancing digital connectivity by initiating construction on its state-of-the-art multi-gigabit fiber network. This investment, amounting to over $11 million, aims to transform the digital landscape for homes and businesses. The company envisions an upgraded digital...

Continue Reading
ONE Gas Boosts Commercial Paper Program for Financial Flexibility

Updated Category News Views 67

ONE Gas Expands Its Commercial Paper Program ONE Gas, Inc. (NYSE: OGS), a prominent natural gas distribution company, has announced a significant increase in the limit of its commercial paper program. This update, disclosed through a recent SEC filing, raises the program's ceiling from $1.275 billion to $1.35 billion, reflecting the company's proactive approach in...

Continue Reading
Sogeclair's Voting Rights Update for Stakeholders in 2025

Updated Category News Views 133

Sogeclair's Insights on Voting Rights and Share Capital SOGECLAIR As a prominent business corporation with a capital of 3,204,901 Euros, Sogeclair is dedicated to maintaining transparency in its operations. The company is headquartered at 7 Avenue Albert Durand, BLAGNAC (France). If you need to reach out, the contact number is +33 (0)5.61.71.71.71 and more about the...

Continue Reading